ApoGen Biotechnologies

ApoGen Biotechnologies

ApoGen Biotechnologies

As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constantnearly all cancer drug therapies eventually fail due to the development of dru
Founded
2014
Raised
$11M
Follow us
Alexa global traffic share
23 Aug 2018
$4,000,000
Venture capital (Series A)

ApoGen Biotechnologies Raises $4m in Series A Funding

FinSMEs
+3
12 Dec 2016
$7,000,000
Venture capital (Series A)

ApoGen Biotechnologies Raises $7M in Series A Funding

FinSMEs
+3